Ligand Pharmaceuticals Incorporated (FRA:LGDN)
Germany · Delayed Price · Currency is EUR 160.00
+4.00 (2.56%)
At close: Jan 30, 2026
Ligand Pharmaceuticals Market Cap
Ligand Pharmaceuticals has a market cap or net worth of €3.18 billion as of January 30, 2026. Its market cap has increased by 57.14% in one year.
Market Cap
3.18B
Enterprise Value
3.00B
Revenue
214.13M
Ranking
n/a
PE Ratio
76.86
Stock Price
€160.00
Market Cap Chart
Since November 25, 1994, Ligand Pharmaceuticals's market cap has increased from 62.10M to 3.18B, an increase of 5,024.60%. That is a compound annual growth rate of 13.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 3.18B | 0.41% |
| Dec 31, 2025 | 3.17B | 62.07% |
| Dec 31, 2024 | 1.96B | 73.58% |
| Dec 29, 2023 | 1.13B | 6.69% |
| Dec 30, 2022 | 1.06B | -53.48% |
| Dec 31, 2021 | 2.27B | 73.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.45B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 939.90M |
| Berliner Effektengesellschaft AG | 879.96M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |